Endometrial Cancer Clinical Trials in Uniondale, New York

5 studies are recruiting for endometrial cancer in Uniondale, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Ivonescimab in People With Endometrial and Cervical Cancers

    The researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) and/or cervical cancer (CC). The researchers will also look at whether the study drug is safe and causes few or mild side effects in participants.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  2. A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

    The researchers are doing this study to find out whether elacestrant is an effective and safe treatment alone or in combination with abemaciclib for people with advanced or recurrent ER+ endometrial cancer.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau, Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  3. A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

    The purpose of this study is to find out whether short-course radiation therapy (1 week instead of the usual 5 weeks) with chemotherapy (carboplatin and paclitaxel) is practical (feasible), meaning that most participants are able to complete the treatment schedule.

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (All protocol activities), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  4. A Study of a Weight Loss Intervention in People With Endometrial Cancer

    The researchers are doing this study is to find out whether tirzepatide and semaglutide are practical (feasible) for weight management and blood sugar control for endometrial cancer patients undergoing chemotherapy. The researchers will also look at participants' experience with the study drug, the…

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau, Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  5. A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer

    The researchers are doing this study to see how well multiparametric ultrasound (mpUS) imaging can evaluate vaginal tissue before and after IVRT. IVRT is routinely used to treat endometrial cancer but can cause damage to the vaginal tissue (vaginal toxicity). Side effects of vaginal toxicity can in…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (Consent Only), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.